Asthma prescribing according to Arg16Gly beta-2 genotype: a randomised trial in adolescents

Tom Ruffles, Christina J. Jones, Colin Palmer, Steve Turner, Jonathan Grigg, Roger Tavendale, Fiona Hogarth, Petra Rauchhaus, Kristina Pilvinyte, Romanie Hannah, Helen Smith, Roberta Littleford, Brian Lipworth, Somnath Mukhopadhyay

Source: Eur Respir J, 58 (2) 2004107; 10.1183/13993003.04107-2020
Journal Issue: August
Disease area: Airway diseases, Paediatric lung diseases

Congress or journal article abstractFull text journal articlePDF journal article, handout or slides

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Tom Ruffles, Christina J. Jones, Colin Palmer, Steve Turner, Jonathan Grigg, Roger Tavendale, Fiona Hogarth, Petra Rauchhaus, Kristina Pilvinyte, Romanie Hannah, Helen Smith, Roberta Littleford, Brian Lipworth, Somnath Mukhopadhyay. Asthma prescribing according to Arg16Gly beta-2 genotype: a randomised trial in adolescents. Eur Respir J, 58 (2) 2004107; 10.1183/13993003.04107-2020

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Effect of controller prescribing according to rs1042713 genotype on asthma related quality of life in young people (PACT): a randomized controlled trial
Source: Virtual Congress 2020 – ALERT: Asthma in adults and children
Year: 2020




Intermittent montelukast or preschool wheeze, the results of a randomised controlled trial with stratification for ALOX5 promoter genotype
Source: International Congress 2014 – Clinical Trial presentation and discussion "Cysteinyl leukotrienes and paediatric asthma: a new horizon or a blind alley?"
Year: 2014




A randomized, double-blind, placebo-controlled of vitamin D3 for Irish children with asthma: Baseline data
Source: International Congress 2014 – Paediatric asthma: pharmacological and non-pharmacological management
Year: 2014

The Children's Anti-inflammatory Reliever (CARE) study: a protocol for a randomised controlled trial of budesonide-formoterol as sole reliever therapy in children with mild asthma
Source: ERJ Open Res, 7 (4) 00271-2021; 10.1183/23120541.00271-2021
Year: 2021



A randomized controlled trial on office spirometry in asthma and COPD in standard general practice: the SPACE Italian study
Source: Eur Respir J 2005; 26: Suppl. 49, 670s
Year: 2005

Cardioselective beta-blockers are not only safe in patients with COPD, but may also improve the responsibility of FEV1 to beta-agonist: A meta-analysis of randomized controlled double-blinded trials
Source: Annual Congress 2012 - Pharmacological and non-pharmacological management of COPD
Year: 2012

Efficacy of the Plasma Cluster® device in mild to moderate asthmatic children: A randomized, double-blind, placebo-controlled, proof-of-concept trial
Source: Annual Congress 2013 –Asthma treatment and management in children
Year: 2013

Management of COPD in Australian general practices: experiences from a cluster randomised trial
Source: International Congress 2017 – Primary care pulmonary rehabilitation, multimorbidity and organisation of care
Year: 2017

Roflumilast in Asian patients with COPD: A randomised placebo-controlled trial
Source: Annual Congress 2011 - Biomarkers and exacerbations of asthma and COPD
Year: 2011

“Stepping down” in mild-to-moderate asthmatic children being well controlled while receiving low doses of inhaled corticosteroids (ICS): Daily vs. cyclical ICS administration (prospective, randomized, multicentre, open-label trial)
Source: Annual Congress 2013 –Asthma treatment and management in children
Year: 2013


How many adolescents are actually included in randomised trials primarily in adults with asthma? An analysis of recent trial reports
Source: International Congress 2015 – Novel strategies for the management of asthma, COPD and airway infections
Year: 2015


Ketamine versus aminophylline for status asthmatic in children: A randomized, controlled trial
Source: International Congress 2014 – Lung disease in neonates and beyond
Year: 2014

ADRB2 polymorphisms and risk of COPD exacerbations: the Rotterdam Study
Source: International Congress 2019 – Genes and environment
Year: 2019

Effect of ADL- training for persons with COPD: A randomized controlled trial
Source: Annual Congress 2011 - Pulmonary rehabilitation: looking at alternative approaches and alternative populations beyond COPD
Year: 2011


Efficiency of physiotherapy with Caycedian Sophrology on children with asthma: a randomized controlled trial.
Source: International Congress 2018 – Paediatric asthma: new insights in its prevalence, treatment and treatment failure
Year: 2018

ADRB2 haplotypes and risk of exacerbations in asthmatic children and young adults treated with long-acting ß2-agonists: A meta-analysis in the PiCA consortium
Source: International Congress 2019 – Genes and environment
Year: 2019

Clinical effectiveness of self-management of asthma in general practice: a randomized controlled trial
Source: Eur Respir J 2001; 18: Suppl. 33, 518s
Year: 2001

Comparison of an innovative multi-dose inhaler with the attributes of an 'ideal' inhaler: A multicentre randomised controlled trial (RCT)
Source: International Congress 2014 – Rationale behind respiratory drug development
Year: 2014

Effectiveness of an intervention of Urban Training in patients with COPD: a randomized controlled trial
Source: International Congress 2017 – The importance of physical activity in patients with COPD
Year: 2017


A double-blind, double-dummy, randomized study of beclomethasone/formoterol versus fluticasone/salmeterol in treatment of moderate to severe asthma in Taiwan
Source: Annual Congress 2013 –Asthma drugs: new findings
Year: 2013